|Ladenburg Thalmann & Co., Inc.||
Jeffrey S. Cohen
|Zacks Investment Research, Inc.||
John Vandermosten, CFA
Tenax Therapeutics is followed by the analysts listed above. Please note that any opinions, estimates or forecasts regarding Tenax Therapeutics's performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Tenax Therapeutics or its management. Tenax Therapeutics does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations.